Abstract
Many clinical studies have demonstrated all the therapeutic potential of alpha-emitting Actinium-225. Today, SCK CEN and IBA are joining their forces to enable large-scale and high-quality production of this promising radioisotope.
Willem Leysen, Jakub Damian, Lucia-Ana Popescu, Jasper Mermans, Hanna Skliarova, Dominic Maertens, Stephan Heinitz, Guy Scheveneels, Koen Hasaers, Dennis Elema, Sven Van Den Berghe, Cristiana Gameiro, Jean-Michel Geets, Samy Bertrand